FDA Investigator Andrew P Lin
Andrew P Lin has conducted inspections on 6 sites in 1 countries as of 12 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
12 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Andrew P Lin:
Alice A Blair,
Angela D Wise,
Anh M Lac,
Christine M Parmentier,
Claudia Mperez Kasmarski,
Courtney R Bolton,
Craig K Hopkins,
Damon A Growl,
Daniel C Geffin,
Darla R Bracy,
Darlene B Almogela,
Edna J Hidalgo,
Erica R Pomeroy,
James C Yee,
Janice K Gardner,
Janice Wai,
Jeffrey M Watson,
Jennifer S King,
Jenny K Yee,
John A Liu,
John Cook,
Juliane Kjung Lau,
Karla J Gibler,
Lance Mde Souza, MBA,
Lynn L Wong,
Marie K Kinkade,
Marissa J Chan,
Mark I Nakano,
Marshalette O Edwards,
Melody M Ragasa Leong,
Michelle L Tripp,
Navneet Kaur,
Peter E Baker,
Randall J Plunkett,
Randall P Zielinski,
Raymond T Oji,
Sandra S Saniga,
Steven B Chiu,
Stuart Kim,
Stuart W Russell,
Wayne L Jefferson,
Wendy S Shenk,
Wenting Lei,
William J Weis,
William V Millar
Andrew P Lin's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2009 | EIR | Bausch Health Americas, Inc. - EIR, 2009-12-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more